TABLE 1
FROM:
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer
F Miyazono, R Metzger, U Warnecke-Eberz, S E Baldus, J Brabender, E Bollschweiler, W Doerfler, R P Mueller, H P Dienes, T Aikou, A H Hoelscher and P M Schneider
BACK TO ARTICLETable 1. Clinical and histopathologic parameters (patients with tumour resection: 36)
| Parameter | Subtype | Number | % |
|---|---|---|---|
| Histology | Squamous | 23 | 63.9 |
| Adeno | 13 | 36.1 | |
| ypT-categorya | T0 | 2 | 5.6 |
| T1 | 1 | 2.8 | |
| T2 | 7 | 19.4 | |
| T3 | 25 | 69.4 | |
| T4 | 1 | 2.8 | |
| ypN-categoryb | N0 | 15 | 41.7 |
| N1 | 21 | 58.3 | |
| R-categoryc | R0 | 31 | 86.1 |
| R1 | 5 | 13.9 | |
| R2 | 0 | 0 | |
| Grading | G1 | 0 | 0 |
| G2 | 12 | 33.3 | |
| G3 | 24 | 66.7 | |
| Regression graded | I | 15 | 41.7 |
| II | 9 | 25 | |
| III | 10 | 27.8 | |
| IV | 2 | 5.6 |
a Histopathologic tumour category after neoadjuvant therapy according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
b Histopathologic lymph node category after neoadjuvant therapy according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
c Residual tumour category according to UICC (Union Internationale Contre Le Cancer, 5th edition, 1997).
d Grade I: >50% vital residual tumour cells (VRTC), grade II: 10–50% VRTC, grade III: nearly complete response (NCR) with <10% VRTC and grade IV: complete response (pCR, ypT0).
